K. Thomas, U. Proschmann, and T. Ziemssen, Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis, Expert Opin Pharmacother, vol.18, issue.15, pp.1649-60, 2017.

S. Faissner and R. Gold, Efficacy and safety of the newer multiple sclerosis drugs approved since 2010, CNS Drugs, vol.32, issue.3, pp.269-87, 2018.

F. Yoshii, Neurological safety of fingolimod: an updated review, Clin Exp Neuroimmunol, vol.8, issue.3, pp.233-276, 2017.

D. J. Epstein, J. Dunn, and S. Deresinski, Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management, Open Forum Infect Dis, vol.5, issue.8, p.174, 2018.

W. Checkley, A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium, Lancet Infect Dis, vol.15, issue.1, pp.85-94, 2015.

S. M. Caccio and R. M. Chalmers, Human cryptosporidiosis in Europe, Clin Microbiol Infect, vol.22, issue.6, pp.471-80, 2016.

M. Bouzid, Cryptosporidium pathogenicity and virulence, Clin Microbiol Rev, vol.26, issue.1, pp.115-149, 2013.

D. Costa, Human cryptosporidiosis in immunodeficient patients in France, Exp Parasitol, vol.192, pp.108-120, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02902544

G. B. Collaborators, Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the global burden of disease study 2015, Lancet Infect Dis, vol.17, issue.9, pp.909-957, 2017.

I. M. Sulaiman, Unique endemicity of cryptosporidiosis in children in Kuwait, J Clin Microbiol, vol.43, issue.6, pp.2805-2814, 2005.

B. Pantenburg, M. M. Cabada, and A. C. White, Treatment of cryptosporidiosis, Expert Rev Anti-Infect Ther, vol.7, issue.4, pp.385-91, 2009.

B. Z. Chaudhry, J. A. Cohen, and D. S. Conway, Sphingosine 1-phosphate receptor modulators for the treatment of multiple sclerosis, Neurotherapeutics, vol.14, issue.4, pp.859-73, 2017.

M. Hjorth, N. Dandu, and J. Mellergard, Treatment effects of fingolimod in multiple sclerosis: selective changes in peripheral blood lymphocyte subsets, PLoS One, vol.15, issue.2, p.228380, 2020.

A. Borad and H. Ward, Human immune responses in cryptosporidiosis, Future Microbiol, vol.5, issue.3, pp.507-526, 2010.

R. J. Wang, Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: epidemiology, clinical feature, diagnosis, and therapy, Acta Trop, vol.187, pp.257-63, 2018.

S. Khurana and P. Chaudhary, Laboratory diagnosis of cryptosporidiosis, Trop Parasitol, vol.8, issue.1, pp.2-7, 2018.

B. Autier, Comparison of three commercial multiplex PCR assays for the diagnosis of intestinal protozoa, Parasite, vol.25, p.48, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02316651

F. Morio, Assessment of the first commercial multiplex PCR kit (ParaGENIE Crypto-Micro Real-Time PCR) for the detection of Cryptosporidium spp., Enterocytozoon bieneusi, and Encephalitozoon intestinalis from fecal samples, Diagn Microbiol Infect Dis, vol.95, issue.1, pp.34-41, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02483139

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations